Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)

Lancet

Volumn 352, Issue 9129, 1998, Pages 673-681

  Serruys, Patrick W ^a,p   Van Hout, Ben ^b   Bonnier, Hans ^c   Legrand, Victor ^d   Garcia, Eulogio ^e   Macaya, Carlos ^f   Sousa, Eduardo ^g   Van Giessen, Wim Der ^h   Colombo, Antonio ⁱ   Seabra Gomes, Ricardo ^j   Kiemeneij, Ferdinand ^k   Ruygrok, Peter ^l   Ormiston, John ^m   Emanuelsson, Hakan ⁿ   Fajadet, Jean ^o   Haude, Michael ^a   Klugmann, Silvio ^a   Morel, Marie Angèle ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c CATHARINA HOSPITAL   (Netherlands)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e Hospital Universitario Gergorio Maranon   (Spain)

^f HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^g INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^h EMO Centra Cuore Columbus   (Italy)

ⁱ HOSPITAL DE SANTA CRUZ   (Portugal)

^j ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^k GREEN LANE HOSPITAL   (New Zealand)

^l SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^m CLINIQUE PASTEUR   (France)

ⁿ UNIVERSITY OF DUISBURG ESSEN   (Germany)

^o MAGGIORE HOSPITAL   (Italy)

^p ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; HEPARIN; TICLOPIDINE;

ANGINA PECTORIS; ARTERY DIAMETER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; FEMALE; FOLLOW UP; HEALTH CARE COST; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; REVASCULARIZATION; STENT; SURVIVAL; TREATMENT OUTCOME;

EID: 0032578319     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)11128-X     Document Type: Article

References (31)

1. Serruys PW, De Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331: 489-95.
2. Fischman D, Leon M, Baim D, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994; 331: 496-501.
3. Topol E. Caveats about elective coronary stenting. N Engl J Med 1994; 331: 539-41.
4. Serruys PW, Emanuelsson H, Van Der Giessen W, et al. Heparincoated Palmaz-Schatz stents in human coronary arteries: early outcome of the Benestent-II pilot study. Circulation 1996; 93: 412-22.
5. Gawaz M, Neumann FJ, Ott I, May A, Schömig A. Platelet activation and coronary stent implantation: effect of antithrombotic therapy. Circulation 1996; 94: 279-85.
6. Serruys PW, di Mario C. Who was thrombogenic: the stent or the doctor? Circulation 1995; 91: 1891-93.
7. Van Hout B, Van Der Woude T, De Jaegere P, et al. Cost effectiveness of stent implantation versus PTCA: the Benestent experience. Semin Intervent Cardiol 1996; 1: 263-68.
8. Van Hout B, Al M, Gordon G, Rutten F. Cost effects and C/E-ratios alongside a clinical trial. Health Economics 1996; 3: 309-19.
9. Braunwald E. Unstable angina: a classification. Circulation 1989; 80: 410-14.
10. Serruys PW, Strauss BH, Beatt KJ, et al. Angiographic follow-up after placement of a self-expanding coronary-artery stent. N Engl J Med 1991; 324: 13-17.
11. Blackburn H, Keys A, Simon son E, Rautaharju P, Punsar S. The electrocardiogram in population studies: a classification system. Circulation 1960; 21: 1160-75.
12. Escaned J, Folley DP, Haase J, et al. Quantitative angiography during coronary angioplasty with a single angiographic view: a comparison of automated edge detection and videodensitrometric techniques. Am Heart J 1993; 126: 1326-33.
13. Van Hout BA, Bowman L, Zelinger DJ, Simoons ML. Costs and effects in therapy for acute coronary syndromes: the case of abciximab in high-risk patients undergoing percutaneous transluminal coronary angioplasty in the EPIC study. Eur Heart J 1998; 19 (suppl D): D59-66.
14. Brand M van den, Halem C van, Brink van den, et al. Comparison of costs of percutaneous transluminal coronary angioplasty and coronary bypass surgery for patients with angina pectoris. Eur Heart J 1990; 11: 765-71.
15. Greenland S, Robins JM. Estimation of a common effect parameter from sparse follow-up data. Biometrics 1985; 41: 55-68.
16. Fiel1er EC. Some probability interval estimates. J Roy Statist Soc series B 1954; 16: 175-83.
17. Black WC. The cost-effectiveness plane: a graphic representation of cost-effectiveness. Medical Decision Making 1990; 1: 212.
18. Ellis SG, Roubin GS, King SBIII, Douglas JS Jr, Cos WR. Importance of stenosis morphology in the estimation of restenosis risk after elective percutaneous transluminal coronary angioplasty. Am J Cardiol 1989; 63: 30-34.
19. The TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial: phase 1 findings. N Engl J Med 1985; 312: 932-36.
20. Herrman JP, Azar AJ, Umans AWM, Boersma E, Es van GA, Serruys PW. Inter-and intra-observer variability in the qualitative categorization of coronary angiograms. Int J Cardiac Imaging 1996; 12: 21-30.
21. Dorros G, Cowley MJ, Simpson J, et al. Percutaneous transluminal coronary angioplasty: report of complications from the National Heart, Lung and Blood Institute PTCA Registry. Circulation 1983; 67: 723-30.
22. Schömig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996; 334: 1084-89.
23. Serruys PW, Grines CL, Stone GW, et al. Stenting in acute myocardial infarction using a heparin-coated stent: a pilot study as a preamble to a randomized trial comparing balloon angioplasty and stenting. Int J Carciovascular Intervent (in press).
24. Chronos NAF, Robinson KA, King III SB, et al. Heparin coated Palmaz-Schatz stents are highly thrombo-resistant: a baboon A-V shunt study. Am J Coll Cardiol 1996; 27 (suppl A): 904 (abstr).
25. Hard hammer PA, Van Beusekom H , Emanuelsson H V, et al. Reduction of thrombotic events using heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries. Circulation 1996; 93: 423-30.
26. Palmar-Schatz balloon-expandable stent and delivery system: PM A 900043 panel package: circulatory system devices panel: May 3, 1994. Division on cardiovascular, respiratory and neurological devices: US Food and Drug Administration.
27. Bertrant ME, Allain H, Lablanche J. Results of a randomized trial of ticlopidine versus placebo for prevention of acute closure and restenosis after coronary angioplasty (PTCA): the TACT study. Circulation 1990; 82 (suppl III): 190 (abstr).
28. The EPISTENT Investigators. Randomised placebo-controlled and balloon-angioplasty controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet 1998; 352: 87-92.
29. Ellis SG, Serruys PW, Popma JJ, et al. Can abciximab prevent neointimal proliferation in Palmaz-Schatz stents?: the final eraser results. Circulation 1997; 96: 1-87.
30. Erbel R, Haude M, Höpp H W, et al, on behalf of the REST Study Group. Randomized trial comparing stenting and balloon angioplasty for treatment of restenosis after balloon angioplasty. Am J Coll Cardiol 1996; 27 (suppl A): 139 (abstr).
31. Rupprecht H-J, Espinola-Klein C, Erber R, Nafe B, Brennecke R, Dietz U, Meyer J. Impact of routine angiographic follow-up after angioplasty. Am Heart J (in press).